The Association of British Clinical Diabetologists

Achievement of HbA1c targets in the diabetes unmet need with basal insulin Evaluation (DUNE) real-world study

Read more about Achievement of HbA1c targets in the diabetes unmet need with basal insulin Evaluation (DUNE) real-world study

Onset 1: efficacy and safety of mealtime fast‑acting insulin aspart versus insulin aspart after 52 weeks

Read more about Onset 1: efficacy and safety of mealtime fast‑acting insulin aspart versus insulin aspart after 52 weeks

Lower glucose variability and risk for hypoglycaemia on insulin Glargine 300 U/mL versus insulin Glargine 100 U/mL, evaluated by the low blood glucose index in randomized phase lll clinical crials

Read more about Lower glucose variability and risk for hypoglycaemia on insulin Glargine 300 U/mL versus insulin Glargine 100 U/mL, evaluated by the low blood glucose index in randomized phase lll clinical crials

Longer acting basal insulin analogues ‘Toujeo’ and ‘Tresiba’ reduce treatment side effects; a therapeutic advance in selected patients

Read more about Longer acting basal insulin analogues ‘Toujeo’ and ‘Tresiba’ reduce treatment side effects; a therapeutic advance in selected patients

World travel with Type-1 diabetes

Read more about World travel with Type-1 diabetes

Efficacy and safety of insulin degludec/liraglutide (IDegLira) vs. basal–bolus therapy in patients with type 2 diabetes: DUAL VII trial

Read more about Efficacy and safety of insulin degludec/liraglutide (IDegLira) vs. basal–bolus therapy in patients with type 2 diabetes: DUAL VII trial

Day-to-day variability of fasting self-measured blood glucose associates with risk of hypoglycaemia in adults with type 1 and type 2 diabetes

Read more about Day-to-day variability of fasting self-measured blood glucose associates with risk of hypoglycaemia in adults with type 1 and type 2 diabetes

Posters Autumn 2017

Read more about Posters Autumn 2017
Log in or register to post comments

Association of British Clinicial Diabetologists
Autumn Meeting
BMA House, London
9th & 10th November 2017

POSTERS FOR ONLINE VIEWING

Hyperglycaemia rates in oncology patients receiving systemic anti-cancer therapy (SACT)

Read more about Hyperglycaemia rates in oncology patients receiving systemic anti-cancer therapy (SACT)

The diagnostic utility of urinary C-peptide/creatinine ratio (UCPCR): Insights from a review of the local use of UCPCR in the diabetes clinic

Read more about The diagnostic utility of urinary C-peptide/creatinine ratio (UCPCR): Insights from a review of the local use of UCPCR in the diabetes clinic

Subscribe to The Association of British Clinical Diabetologists